Steven Santiago
Adult Medicine · Miami, FLNPI 1316080682
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $197,025 of the $289,608 with a category attached, or 68.0%. 15 manufacturers reported payments, led by Gilead at 46.4% of the total. Reporting peaked in 2019 at $122,176 and has fallen 85.3% since, to $17,953 in 2025. Among adult medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 748 payments — averaging $387.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$134K
- Janssen Scientific Affairs, LLC$118K
- Viiv Healthcare Company$30K
- Theratechnologies Inc.$3K
- Janssen Products, LP$3K
- Johnson & Johnson$846
- plus $926 from 9 others
What the payments were for
- Consulting fees$35,53012%
- Speaking & faculty fees$197,02568%
- Travel & lodging$42,18515%
- Food & beverage$14,8175%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 290 | $134,236 |
| Janssen Scientific Affairs, LLC | 183 | $117,533 |
| Viiv Healthcare Company | 154 | $30,437 |
| Theratechnologies Inc. | 30 | $2,989 |
| Janssen Products, LP | 2 | $2,640 |
| Johnson & Johnson(2 entities) | 51 | $846 |
| Merck | 19 | $348 |
| EMD Serono, Inc. | 5 | $323 |
| Exact Sciences | 6 | $113 |
| Pfizer | 3 | $63 |
| Amgen | 1 | $19 |
| Insulet Corporation | 1 | $16 |
| Napo Pharmaceuticals Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$289,608 in reported general payments places this provider in the 95th percentile of 195 adult medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 129 | $499,433 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 25 | $126,417 |
| CabenuvaCabotegravir/Rilpivirine | 19 | $117,523 |
| DovatoDolutegravir Sodium/Lamivudine | 32 | $98,191 |
| JulucaDolutegravir/Rilpivirine | 11 | $44,047 |
| TivicayDolutegravir Sodium | 18 | $43,904 |
| MytesiCrofelemer | 13 | $30,758 |
| OzempicSemaglutide | 16 | $16,637 |
| ValacyclovirValacyclovir Hcl | 24 | $958 |
| Rosuvastatin Calcium | 42 | $882 |
| Pregabalin | 14 | $321 |
| Gabapentin | 20 | $253 |
| Zolpidem Tartrate | 21 | $156 |
| Losartan Potassium | 13 | $156 |
| Ketoconazole | 12 | $128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $134,236 | $499,433129 claims |
| Viiv Healthcare CompanyCabenuva, Dovato, Juluca, Tivicay | $30,437 | $303,66680 claims |
| Janssen Products, LPSymtuza | $2,640 | $126,41725 claims |
| Napo Pharmaceuticals IncMytesi | $15 | $30,75813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 195 adult medicine providers in Florida.
Other adult medicine in Miami
- Hernando ChongMiami$9K
- Agustin AlfonsoMiami$1K
- Tammy DsouzaKissimmee$191K
- Eric SchertzerPlantation$26K
- Ricardo SerranoMerritt Island$20K
- Marlene JarinMiami Beach$18K
- Myra ReedPanama City Beach$16K
- Joshua RycusCoral Springs$13K
- Frederick WeigandDeltona$9K
- Neri FranzonFt Lauderdale$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.